AI-generated summary
In this mouse study, the authors examined whether red light therapy at 660 nm promoted new blood vessel growth in diabetic and non-diabetic mice with induced hindlimb ischemia. The authors report that treated mice had more than double the capillary density and blood perfusion rate compared with untreated controls, along with increased VEGF-A and HIF-1α. These are animal findings, and the authors suggest the approach could be a treatment for peripheral arterial disease, which the abstract does not establish in people.
- Who or what was studied
- Diabetic and non-diabetic mice with femoral artery ligation/excision inducing hindlimb ischemia
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The study was conducted in mice, and the abstract does not report a human sample or clinical outcomes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Energy density (fluence)
- 1.91 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Laser, Angiogenesis, Photobiomodulation, Nitric oxide, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.